FDA Finds Another Example Of Quality Control Problems At Guidant
This article was originally published in The Gray Sheet
Executive Summary
A recent FDA inspection of Guidant's cardiac rhythm management facilities in St. Paul resulted in one new observation about a potential quality control problem at the site, the company reported Feb. 23